89 related articles for article (PubMed ID: 17127389)
1. Hormone treatment enhances WT1 activation of Renilla luciferase constructs in LNCaP cells.
Hanson J; Reese J; Gorman J; Cash J; Fraizer G
Front Biosci; 2007 Jan; 12():1387-94. PubMed ID: 17127389
[TBL] [Abstract][Full Text] [Related]
2. Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1.
Hanson J; Gorman J; Reese J; Fraizer G
Front Biosci; 2007 Jan; 12():2279-90. PubMed ID: 17127464
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells.
Graham K; Li W; Williams BR; Fraizer G
Gene Expr; 2006; 13(1):1-14. PubMed ID: 16572586
[TBL] [Abstract][Full Text] [Related]
5. VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
Cash J; Korchnak A; Gorman J; Tandon Y; Fraizer G
Oncol Rep; 2007 Jun; 17(6):1413-9. PubMed ID: 17487399
[TBL] [Abstract][Full Text] [Related]
6. False responses of Renilla luciferase reporter control to nuclear receptor TR4.
Zhang D; Atlasi SS; Patel KK; Zhuang Z; Heaney AP
Mol Cell Biochem; 2017 Jun; 430(1-2):139-147. PubMed ID: 28210900
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects associated with use of modified Photinus pyralis and Renilla reniformis luciferase vectors in dual reporter assays and implications for analysis of ISGs.
Ghazawi I; Cutler SJ; Low P; Mellick AS; Ralph SJ
J Interferon Cytokine Res; 2005 Feb; 25(2):92-102. PubMed ID: 15695930
[TBL] [Abstract][Full Text] [Related]
8. Androgen responsiveness of Renilla luciferase reporter vectors is promoter, transgene, and cell line dependent.
Mulholland DJ; Cox M; Read J; Rennie P; Nelson C
Prostate; 2004 May; 59(2):115-9. PubMed ID: 15042611
[TBL] [Abstract][Full Text] [Related]
9. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.
Liao X; Thrasher JB; Pelling J; Holzbeierlein J; Sang QX; Li B
Endocrinology; 2003 May; 144(5):1656-63. PubMed ID: 12697668
[TBL] [Abstract][Full Text] [Related]
10. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
11. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3eta.
Haendler B; Schüttke I; Schleuning WD
Mol Cell Endocrinol; 2001 Feb; 173(1-2):63-73. PubMed ID: 11223178
[TBL] [Abstract][Full Text] [Related]
13. Promoter deletion analysis using a dual-luciferase reporter system.
Xu YZ; Kanagaratham C; Jancik S; Radzioch D
Methods Mol Biol; 2013; 977():79-93. PubMed ID: 23436355
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme.
Beaulieu M; Lévesque E; Tchernof A; Beatty BG; Bélanger A; Hum DW
DNA Cell Biol; 1997 Oct; 16(10):1143-54. PubMed ID: 9364925
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
16. Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells.
Ripple MO; Henry WF; Schwarze SR; Wilding G; Weindruch R
J Natl Cancer Inst; 1999 Jul; 91(14):1227-32. PubMed ID: 10413424
[TBL] [Abstract][Full Text] [Related]
17. Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.
Ulrix W; Swinnen JV; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1999 Sep; 155(1-2):69-76. PubMed ID: 10580840
[TBL] [Abstract][Full Text] [Related]
18. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
19. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
20. Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications.
Ripple MO; Hagopian K; Oberley TD; Schatten H; Weindruch R
Antioxid Redox Signal; 1999; 1(1):71-81. PubMed ID: 11225734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
